PT-141 (Bremelanotide)
Also known as: PT-141, Bremelanotide, Vyleesi, PT141
PT-141 (Bremelanotide) is a melanocortin-receptor agonist that has been studied in the context of sexual function and has an approved indication for certain patients in that area. It is typically described as being used on an as-needed basis. This entry is informational and is not a recommendation to use the compound.
At a glance
| Category | Cosmetic & Other |
|---|---|
| Class | peptide, melanocortin-agonist |
| Half-life | 2.7 hours |
| Typical route | subcutaneous |
| Common vial strengths | 5 mg, 10 mg |
| Storage | Lyophilized powder is commonly stored frozen or refrigerated; reconstituted solutions are typically kept refrigerated. |
Elimination curve
Full clearance milestones on the PT-141 (Bremelanotide) half-life page.
Doing the vial math? The PT-141 (Bremelanotide) reconstitution calculator converts mg to insulin-syringe units, free and without an account.
Questions, answered.
What is PT-141 (Bremelanotide)?
What is PT-141 (Bremelanotide)'s half-life?
Is PT-141 (Bremelanotide) the same as PT-141 or Bremelanotide or Vyleesi or PT141?
What do people log alongside PT-141 (Bremelanotide)?
Educational information for people who track their protocols — not medical advice, and never a recommendation to use any compound. Always work with a qualified healthcare provider.
Track PT-141 (Bremelanotide) with one-tap dose logs, estimated level charts, site rotation, and reminders — free for your first 3 days.